Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride
Key facts
Active substance |
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/74/2009
|
PIP number |
Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride
|
Pharmaceutical form(s) |
Capsule
|
Condition(s) / indication(s) |
Helicobacter pylori infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Axcan Pharma SA
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|